-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Candel Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2024.
- Candel Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2025 was $314K, a 69.9% decline year-over-year.
- Candel Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2025 was $4.58M, a 34.8% increase year-over-year.
- Candel Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $5.31M, a 71.9% increase from 2023.
- Candel Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.09M, a 34% increase from 2022.
- Candel Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.31M, a 22.1% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)